Novartis Pharmaceuticals Business Systems Analyst Salaries in Boulder
The average Novartis Pharmaceuticals Business Systems Analyst in Boulder earns an estimated $85,277 annually, which includes an estimated base salary of $79,236 with a $6,041 bonus. Novartis Pharmaceuticals' Business Systems Analyst compensation is $1,806 more than the US average for a Business Systems Analyst. Business Systems Analyst salaries at Novartis Pharmaceuticals in Boulder can range from $52,000 - $121,000.
In Boulder, The Operations Department at Novartis Pharmaceuticals earns $12,169 more on average than the Sales Department.
Last updated 2 years ago.
- $79,236
- avg. base
- $6,041
- avg. bonus
Business Systems Analyst Salaries at Novartis Pharmaceuticals
In Boulder, Business Systems Analysts earn $2,817 more than Business Analysts, and $7,555 less than Operations Managers.
Compensation at Novartis Pharmaceuticals by Department
In Boulder, The Operations Department averages $12,169 more than the Sales Department, and $2,216 less than the Customer Support Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to Novartis Pharmaceuticals reported making $89,933, while the average male Business Systems Analyst at similar sized companies reported making $93,781.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Systems Analyst at companies similar size to Novartis Pharmaceuticals reported making $115,000, while the average African American/Black Business Systems Analyst at similar sized companies reported making $75,705.
How Business Systems Analysts at Novartis Pharmaceuticals Rate Their Compensation
The majority of Business Systems Analysts at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Business Systems Analysts at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
